Skip to main content
VulnerabilityPublished

CVE-2026-123052: The CeliachiaRL integration component distributed with Farmasimplex uses shared OAuth credentials

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-123052· Medium 4.7

Not known to be exploited · CVSS 4.7 Medium : upgrade to 16.2.0 when convenient.

Data as of 17 Nov 2026, 16:50 UTC

CVSS 4.0 base score
4.7Medium
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (ENISA)CVSS 4.04.7
Patch
Available – fixed in 16.2.0
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:U

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 17 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Upgrade Farmasimplex CeliachiaRL to 16.2.0.

Affected software

ProductAffectedFixed in
CIPCarboneFarmasimplex CeliachiaRLAffected
  • <16.2.0
Fixed in
  • 16.2.0

AI-suggested

Since the vulnerability involves shared OAuth credentials, mitigation should focus on isolating credentials per installation and rotating compromised credentials if possible. Until a fix is provided, avoid sharing OAuth credentials across multiple installations.

Description

The CeliachiaRL integration component used in Farmasimplex shares OAuth credentials across multiple customer installations. This shared credential usage allows an attacker who obtains credentials from one installation to potentially access or modify data in other installations. The vulnerability could lead to unauthorized access to sensitive information or unauthorized modification of integration data.

References

Community reviews

Loading reviews…